Pfizer wins $10 billion bidding war for Metsera as Novo bows out
In a significant development that has captured global attention in the pharmaceutical industry, Pfizer Inc. has officially won the bidding war for Metsera, a fast-growing biotech company focused on rare diseases and gene therapy, for an estimated $10 billion. This acquisition marks one of Pfizer’s most ambitious moves in recent years, signaling its continued push … Read more